| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.9 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.023 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.024 | 0.9 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |